GE HealthCare Technologies (FRA:L0T) LT-Debt-to-Total-Asset : 0.23 (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is GE HealthCare Technologies LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. GE HealthCare Technologies's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.23.

GE HealthCare Technologies's long-term debt to total assets ratio declined from Dec. 2023 (0.27) to Dec. 2024 (0.23). It may suggest that GE HealthCare Technologies is progressively becoming less dependent on debt to grow their business.

GE HealthCare Technologies LT-Debt-to-Total-Asset Historical Data

The historical data trend for GE HealthCare Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GE HealthCare Technologies LT-Debt-to-Total-Asset Chart

GE HealthCare Technologies Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.31

0.27

0.23

GE HealthCare Technologies Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial											0.27	0.27	0.27	0.28	0.23

GE HealthCare Technologies LT-Debt-to-Total-Asset Calculation

GE HealthCare Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	7409.845	/	31599.995
	=	0.23

GE HealthCare Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	7409.845	/	31599.995
	=	0.23

GE HealthCare Technologies (FRA:L0T) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

GE HealthCare Technologies LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of GE HealthCare Technologies's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

GE HealthCare Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GE HealthCare Technologies Inc (FRA:L0T) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

GEHC:USA GEHC:Mexico GEHC34:Brazil

Address

500 West Monroe Street, Chicago, IL, USA, 60661

Website

https://www.gehealthcare.com

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

GE HealthCare Technologies Headlines

No Headlines